NCT06026696View on ClinicalTrials.gov

Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière

Not yet recruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

September 30, 2033

Study Completion Date

September 30, 2038

Conditions
Ischemic StrokeHemorrhagic Stroke
Interventions
OTHER

follow-up

Long term follow-up

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière | Biotech Hunter | Biotech Hunter